LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Prepaid Expense and Other Assets
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.59 million for the 9-month period ending 2024-02-25, per its 10-Q filed 2024-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2024-08-09
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-02-25 was $155.00K, a 73.46% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-11-26 was -$4.17M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-08-27 was $2.43M, a 228.28% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-05-28 was -$3.46M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.16M, a 412.92% decline from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $689.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was -$8.28M, a 221.51% decline from fiscal 2020.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $6.82M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-02-25 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$4.01M derived: sum of 2 quarters · filed 2024-08-09 | -$1.59M 10-Q · filed 2024-08-09 | -$5.05M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-11-26 | -$4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.74M 10-Q · filed 2024-08-09 | -$5.21M derived: sum of 3 quarters · filed 2024-08-09 | -$4.62M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-08-27 | $2.43M 10-Q · filed 2024-08-09 | -$1.04M derived: sum of 2 quarters · filed 2024-08-09 | -$455.00K derived: sum of 3 quarters · filed 2024-08-09 | -$469.00K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-05-28 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$2.88M derived: sum of 2 quarters · filed 2024-08-09 | -$2.90M derived: sum of 3 quarters · filed 2024-08-09 | -$2.16M 10-K · filed 2024-03-20 | ||||
| 2023-02-26 | $584.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $570.00K derived: sum of 2 quarters · filed 2024-08-09 | $1.31M 10-Q · filed 2024-08-09 | $1.17M 10-Q · filed 2023-06-02 | $558.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2022-11-27 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $725.00K 10-Q · filed 2024-08-09 | $585.00K 10-Q · filed 2023-03-16 | -$26.00K derived: sum of 3 quarters · filed 2024-08-09 | -$524.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2022-08-28 | $739.00K 10-Q · filed 2024-08-09 | $761.00K 10-Q · filed 2022-10-07 | -$12.00K derived: sum of 2 quarters · filed 2024-08-09 | -$510.00K derived: sum of 3 quarters · filed 2024-08-09 | -$1.17M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2022-05-29 | -$751.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | -$1.25M derived: sum of 2 quarters · filed 2024-03-20 | -$1.91M derived: sum of 3 quarters · filed 2024-03-20 | $689.00K 10-K · filed 2024-03-20 | $602.00K 10-K · filed 2022-09-14 | |||
| 2022-02-27 | -$498.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | -$1.16M derived: sum of 2 quarters · filed 2024-03-20 | $1.44M 10-K · filed 2024-03-20 | $1.45M 10-Q · filed 2022-04-07 | -$5.13M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-11-28 | -$664.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | $1.94M 10-K · filed 2024-03-20 | $1.78M 10-Q · filed 2022-01-07 | -$4.63M derived: sum of 3 quarters · filed 2024-03-20 | -$4.80M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-08-29 | $2.60M 10-K · filed 2024-03-20 | $2.70M 10-Q · filed 2021-10-05 | -$3.96M derived: sum of 2 quarters · filed 2024-03-20 | -$4.14M derived: sum of 3 quarters · filed 2024-03-20 | -$4.31M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-05-30 | -$6.57M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | -$6.74M derived: sum of 2 quarters · filed 2024-03-20 | -$6.92M derived: sum of 3 quarters · filed 2024-03-20 | -$8.28M 10-K · filed 2024-03-20 | -$7.94M 10-K · filed 2021-07-29 | |||
| 2021-02-28 | -$176.00K derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | -$349.00K derived: sum of 2 quarters · filed 2024-03-20 | -$1.72M 10-K · filed 2024-03-20 | -$350.00K 10-Q · filed 2022-04-07 | ||||
| 2020-11-29 | -$173.00K derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | -$1.54M 10-Q · filed 2022-01-07 | ||||||
| 2020-08-30 | -$1.37M 10-K · filed 2024-03-20 | -$1.35M 10-Q · filed 2021-10-05 | ||||||
| 2020-05-31 | $6.82M 10-K/A · filed 2023-03-16 | |||||||
| 2019-05-26 | -$1.60M 10-K · filed 2021-07-29 | |||||||
| 2015-05-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $2.35M derived: sum of 2 quarters · filed 2015-07-31 | $753.00K derived: sum of 3 quarters · filed 2015-07-31 | $2.17M 10-K · filed 2015-07-31 | ||||
| 2015-03-01 | $617.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$981.00K derived: sum of 2 quarters · filed 2015-04-02 | $441.00K 10-Q · filed 2015-04-02 | $270.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-11-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$176.00K 10-Q · filed 2015-01-09 | -$347.00K derived: sum of 3 quarters · filed 2015-07-31 | -$1.50M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-08-31 | $1.42M 10-Q · filed 2014-10-08 | $1.25M derived: sum of 2 quarters · filed 2015-07-31 | $93.00K derived: sum of 3 quarters · filed 2015-07-31 | $1.49M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-05-25 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$1.33M derived: sum of 2 quarters · filed 2015-07-31 | $72.00K derived: sum of 3 quarters · filed 2015-07-31 | $32.00K 10-K · filed 2015-07-31 | ||||
| 2014-02-23 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $243.00K derived: sum of 2 quarters · filed 2015-04-02 | $203.00K 10-Q · filed 2015-04-02 | -$3.14M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-11-24 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $1.36M 10-Q · filed 2015-01-09 | -$1.98M derived: sum of 3 quarters · filed 2015-07-31 | $1.20M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-08-25 | -$40.00K 10-Q · filed 2014-10-08 | -$3.38M derived: sum of 2 quarters · filed 2015-07-31 | -$198.00K derived: sum of 3 quarters · filed 2015-07-31 | -$22.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-05-26 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$158.00K derived: sum of 2 quarters · filed 2015-07-31 | $18.00K derived: sum of 3 quarters · filed 2015-07-31 | $278.00K 10-K · filed 2015-07-31 | ||||
| 2013-02-24 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $3.36M derived: sum of 2 quarters · filed 2014-03-28 | $3.62M 10-Q · filed 2014-03-28 | $3.04M 10-Q · filed 2013-04-04 | $3.61M derived: sum of 4 quarters · filed 2014-08-01 | |||
| 2012-11-25 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $436.00K 10-Q · filed 2014-01-03 | $425.00K derived: sum of 3 quarters · filed 2014-08-01 | -$2.50M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-08-26 | $260.00K 10-Q · filed 2013-09-26 | -$260.00K 10-Q · filed 2012-10-03 | $249.00K derived: sum of 2 quarters · filed 2014-08-01 | -$2.68M derived: sum of 3 quarters · filed 2014-08-01 | -$3.13M derived: sum of 4 quarters · filed 2014-08-01 | |||
| 2012-05-27 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | -$2.94M derived: sum of 2 quarters · filed 2014-08-01 | -$3.39M derived: sum of 3 quarters · filed 2014-08-01 | -$3.59M 10-K · filed 2014-08-01 | ||||
| 2012-02-26 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | -$3.38M derived: sum of 2 quarters · filed 2013-04-04 | -$3.58M 10-Q · filed 2013-04-04 | $3.58M 10-Q · filed 2012-03-28 | -$5.00M derived: sum of 4 quarters · filed 2013-08-07 | |||
| 2011-11-27 | -$457.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$652.00K 10-Q · filed 2013-01-04 | $652.00K 10-Q · filed 2012-01-05 | -$2.08M derived: sum of 3 quarters · filed 2013-08-07 | ||||
| 2011-08-28 | -$195.00K 10-Q/A · filed 2013-01-02 | $195.00K 10-Q · filed 2011-10-05 | -$1.62M derived: sum of 2 quarters · filed 2013-08-07 | |||||
| 2011-05-29 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$602.00K 10-K · filed 2013-08-07 | ||||||
| 2011-02-27 | $824.00K 10-Q · filed 2012-03-28 | |||||||
| 2010-11-28 | $1.53M 10-Q · filed 2012-01-05 | |||||||
| 2010-08-29 | $762.00K 10-Q · filed 2011-10-05 | |||||||
| 2010-05-30 | $1.17M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |